¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cardiac electrophysiology review."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardiac cirrhosis
    ½ÉÀ强°£°æÈ­(Áõ)
  • cardiac compression
    ½ÉÀå¾Ð¹Ú
  • cardiac crisis
    ½ÉÀå¹ßÀÛ, ½ÉÀåÀ§±â
  • cardiac death
    ½ÉÀå»ç
  • cardiac edema
    ½ÉÀ强ºÎÁ¾
  • cardiac excitability
    ½ÉÀåÈïºÐ¼º
  • cardiac failure
    ½ÉÀå±â´É»ó½Ç, ½É(Àå)ºÎÀü
  • cardiac function curve
    ½ÉÀå±â´É°î¼±
  • cardiac gating
    ½ÉÀ嵿±â
  • cardiac gland
    µé¹®»ù, ºÐ¹®¼±
  • cardiac impression
    ½ÉÀåÀÚ±¹, ½ÉÀå¾ÐÈç
  • cardiac impulse
    ½ÉÀå¹Úµ¿
  • cardiac index
    ½ÉÀå¹ÚÃâÁö¼ö
  • cardiac infarction
    ½É±Ù°æ»öÁõ, ½ÉÀå±ÙÀ°°æ»öÁõ
  • cardiac jelly
    ½ÉÀåÁ©¸®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardiac crisis
    ½ÉÀå¹ßÀÛ, ½ÉÀåÀ§±â
  • cardiac death
    ½ÉÀå»ç
  • cardiac defibrillator
    ½ÉÀåÁ¦¼¼µ¿±â, ½ÉÀåÀܶ³¸²Á¦°Å±â
  • cardiac excitability
    ½ÉÀåÈïºÐ¼º
  • cardiac failure
    (¢¡heart failure) ½ÉÀå±â´É»ó½Ç, ½ÉÀåºÎÀü
  • cardiac gating
    ½ÉÀ嵿±â
  • cardiac gland
    µé¹®»ù
  • cardiac impression
    ½ÉÀåÀÚ±¹
  • cardiac impulse
    ½ÉÀå¹Úµ¿, ½É°èµ¿
  • cardiac index
    ½ÉÀå¹ÚÃâ°è¼ö
  • cardiac infarction
    ½ÉÀå±ÙÀ°°æ»öÁõ, ½É±Ù°æ»öÁõ
  • cardiac jelly
    ½ÉÀåÁ©¸®
  • cardiac lung
    ½ÉÀåÅ¿ÇãÆÄ, ½É¼ºÆó, ¿ïÇ÷Æó
  • cardiac murmur
    ½ÉÀåÀâÀ½
  • cardiac myxoma
    ½ÉÀåÁ¡¾×Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inferior cervical cardiac nerve
    ¾Æ·¡¸ñ½ÉÀå½Å°æ
  • primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • relative cardiac dullness
    »ó´ë½ÉŹÀ½°è(ßÓÓßãýöúëåÍ£).
  • relative cardiac dullness
    »ó´ë½ÉŹÀ½°è(ßÓÓßãýöúëåÍ£)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • black cardiac syndrome
    Èæ½ÉÀåÁõÈıº(ýÙãýòÅñøý¦ÏØ).
  • cardiac
    ½ÉÀåÀÇ(ãýíô- ).
  • cardiac
    1. ½ÉÀå(¼º)(ãýíôàõ)ÀÇ. 2. ºÐ¹®(ÝÄÚ¦)ÀÇ.
  • cardiac
    ºÐ¹®ÀÇ(À§), ½ÉÀå(ãýíô)ÀÇ
  • cardiac allograft
    ½ÉÀå µ¿Á¾À̽Ä(ãýíôÔÒðúì¹ãÕ)
  • cardiac amyloidosis
    ½É¾Æ¹Ì·ÎÀ̵µÁõ À¯ÀüºÐÁõ(ãý-ñø ëºîþÝÏñø)
  • cardiac anomaly
    ½É(Àå)ÀÌ»ó(ãýíôì¶ßÈ),±âÇü(ѱû¡)
  • cardiac apex<³ª> a. cordis
    ½É÷(ãýôÓ).
  • cardiac apex<³ª>a. cordis
    ½É÷(ãýôÓ)
  • cardiac arrest
    ½ÉÁ¤Áö(ãýïÎò­)
  • cardiac arrest
    ³»°ú½ÉÁ¤Áö(ãýïÎò­).
  • cardiac arrhythmia
    ½ÉºÎÁ¤¸Æ
  • cardiac assist
    ½Éº¸Á¶(ãýÜÍð¾).
  • cardiac assist device
    ½Éº¸Á¶±â±¸(ãýÜÍð¾ÐïÎý)
  • cardiac asthma ; cardiasthma
    ½ÉÀμºÃµ½Ä(ãýì×àõô·ãÓ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Cardiac prominence
    ½ÉÀåÀ¶±â
    [¿¾ ¿ë¾î] ½ÉÀåÀ¶±â
  • Cardiac impression
    ½ÉÀåÀÚ±¹
    [¿¾ ¿ë¾î] ½É¾ÐÈç
  • Cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀÚ±ØÀüµµ°è
  • Cardiac veins
    ½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æ
  • Inferior cervical cardiac branches
    ¾Æ·¡¸ñ½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] Çϰæ½ÉÀåÁö
  • Inferior cervical cardiac nerve
    ¾Æ·¡¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Çϰæ½ÉÀå½Å°æ
  • Primitive cardiac bulb
    ¿ø½Ã½ÉÀ寨´ë
    [¿¾ ¿ë¾î] ¿ø½Ã½É±¸
  • Cardiac gland
    À§µé¹®»ù
    [¿¾ ¿ë¾î] ºÐ¹®¼±
  • Secretory cell of cardiac gland
    À§µé¹®»ù¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐ¹®¼±¼¼Æ÷
  • Superior cervical cardiac branches
    À§¸ñ½ÉÀå°¡Áö
    [¿¾ ¿ë¾î] »ó°æ½ÉÀåÁö
  • Superior cervical cardiac nerve
    À§¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] »ó°æ½ÉÀå½Å°æ
  • Small cardiac vein
    ÀÛÀº½ÉÀåÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò½ÉÀåÁ¤¸Æ
  • Middle cervical cardiac nerve
    Áß°£¸ñ½ÉÀå½Å°æ
    [¿¾ ¿ë¾î] Áß°æ½ÉÀå½Å°æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
DUR drug use review; drug utilization review
MEDPAR Medical Provider Analysis and Review; Medicare Provider Analysis and Review
PRC packed red cells; peer review committee; phase response curve; plasma renin concentration; professio...
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PRO Peer Review Organization
PSRO Professional Standards Review Organization
RRC Residency Review Committee
UR Utilisation review
ACI Acute cardiac ischemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cardiac branch
    ½ÉÀå °¡Áö, ½ÉÀåÁö
    ½ÉÀå¿¡¼­ ºÐÇÒ ¶Ç´Â ÆÄ»ýÇÑ °Í.
  • cardiac catheter
    ½ÉÀå Ä«Å×ÅÍ
    X¼± Åõ½ÃÇÏ¿¡ ¸»ÃÊÇ÷°üÀ» ÅëÇÏ¿© ½É¹æ, ½É½Ç¿¡ »ðÀÔÇϵµ·Ï ¸¸µç Ư¼ö Ä«Å×ÅÍ.
  • cardiac chamber
    ½É½Ç
    µ¿ÀǾî=cardiac ventricle.
  • cardiac compensation
    ½ÉÀå ´ë»ó
    ½ÉÀå°ú °ü·ÃµÈ Áõ»óÀ» ³ªÅ¸³»Áö ¾Ê°Ô ½ÉÀåÀÌ ÀûÀýÇÑ Ç÷·ù·®À» À¯ÁöÇϰí ÀÖ´Â °Í.
  • cardiac contraction
    ½ÉÀå ¼öÃà
    ½ÉÀå±ÙÀ°ÀÇ ¼öÃà°ú °ü·ÃÇÏ¿© ´ÜÃà°ú ±äÀåÀÇ ¹ß»ýÀ» ¶æÇÑ´Ù.
  • cardiac cycle
    ½ÉÀå ÁÖ±â, ½É ÁÖ±â
    ½É¹æ°ú ½É½ÇÀº ½Ã°£ÀûÀ¸·Î µ¿½Ã´Â ¾Æ´ÏÁö¸¸ ¼öÃà°ú È®ÀåÀ» °ÅµìÇϰí ÀÖ°í, ÀÌ ÁÖ±âÀûÀΠȰµ¿ÀÌ ½É¹Úµ¿ÀÌ°í ½É¹Úµ¿ÀÇ Áֱ⸦ ½ÉÁÖ±â¶ó°í ÇÑ´Ù.
  • cardiac decompensation
    ½É´ë»ó ºÎÀü, ½É½ÇÁ¶, ½ÉÀå ½ÇÁ¶, ½É ±â´É ´ë»ó ºÎÀü
    ½ÉÀåÀÌ ´ë»ó¼º ±â´É Áï ºñ´ë³ª ºó¸Æ µîÀ¸·Î ÃæºÐÈ÷ ¼øÈ¯ Ç÷·ù·®À» À¯ÁöÇÏÁö ¸øÇÏ´Â »óÅÂ.
  • cardiac depressant
    ½É ¾ïÁ¦Á¦
    ½É¹Ú ¼öÀÇ °¨¼Ò¿Í ½ÉÀå ¼öÃà·ÂÀÇ ÀúÇϸ¦ ÀÏÀ¸Å°´Â ¾à¹°.
  • cardiac disorder
    ½ÉÀå Áúȯ
    ½ÉÀåÀÇ Àå¾Ö, ºÎÁ¶È­, Áúȯ. ±â´ÉÀÇ È¥¶õ ¶Ç´Â ºñÁ¤»ó.
  • cardiac dysfunction
    ½É ±â´É Àå¾Ö, ½ÉÀå ±â´É Àå¾Ö
    ½ÉÀåÀÇ ±â´ÉÀå¾Ö ¶Ç´Â ÀÌ»ó.
  • cardiac failure
    ½ÉºÎÀü, ½ÉºÎÀüÁõ
    µ¿ÀǾî=heart failure. ÃæºÐÇÑ Á¤¸Æ Ãæ¸¸¾ÐÀÌ Àִµ¥µµ »ýüÀÇ ¼ö¿ä¿¡ ´ëÇØ¼­ ÀûÀýÇÑ ¼øÈ¯À» À¯ÁöÇÒ ¼ö ¾ø°Ô µÈ »óÅÂ.
  • cardiac gating
    ½ÉÀå µ¿±â
  • cardiac glycosides
    ½ÉÀå ±Û¶óÀÌÄÚ»çÀ̵å
    ½ÉÀåÀ» °­È­Çϱâ À§ÇØ »ç¿ëµÇ´Â ź¼öÈ­¹° ºÐÀÚ¸¦ ÇÔÀ¯ÇÑ È­ÇÕ¹°ÀÇ ÃÑĪ.
  • cardiac infarction
    ½É±Ù °æ»öÁõ
    µ¿ÀǾî=myocardial infarction. ½ÉÀå Æ¯È÷ ½É±Ù¿¡ ³ªÅ¸³­ °æ»öÁõ.
  • cardiac jelly
    ½ÉÀå ±³¾çÁú
    ÅÂ¾Æ ½ÉÀåÀÇ ³»ÇÇ¿Í ½É±ÙÃþ »çÀÌ¿¡ ÀÖ´Â ¹°Áú·Î, ½É³»¸·ÀÇ °áÇÕÁ¶Á÷À¸·Î º¯È­µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
scientific integrity review Designation for reports by the united states office of research integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the nih guide for grants and contracts.
(12 Dec 1998)
drug utilization review Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993.
(12 Dec 1998)
insurance claim review Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.
(12 Dec 1998)
utilization review An organised procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.
(12 Dec 1998)
abnormal cleavage of cardiac valve Congenital malformation of a valve leaflet with a defect extending from the free margin.
(05 Mar 2000)
anterior cardiac veins Two or three small veins in the anterior wall of the right ventricle opening directly into the right atrium independently of the coronary sinus.
Synonym: venae cordis anteriores.
(05 Mar 2000)
area of cardiac dullness A triangular area determined by percussion of the front of the chest; it corresponds to the part of the heart that is not covered by lung tissue.
(05 Mar 2000)
cardiac <cardiology> Pertaining to the heart.
Origin: L. Cardiacus from Gr. Kardiakos
(16 Dec 1997)
cardiac accident Sudden cardiac catastrophe, such as may result from coronary occlusion.
(05 Mar 2000)
cardiac albuminuria Albuminuria caused by congestive heart failure.
(05 Mar 2000)
cardiac alternation The occurrence of any cardiac phenomenon every other beat.
(05 Mar 2000)
cardiac aneurysm Thinning, stretching, and bulging of a weakened ventricular wall, usually as a result of myocardial infarction; rarely postinflammatory or congenital.
Synonym: mural aneurysm, ventricular aneurysm.
(05 Mar 2000)
cardiac arrest This refers to the complete cessation of cardiac activity (heartbeat).
(27 Sep 1997)
cardiac arrhythmia A disturbance the electrical activity of the heart that manifests as an abnormality in heart rate or heart rhythm. Patients with a cardiac arrhythmia may experience a wide variety of symptoms ranging from palpitations to fainting.
(27 Sep 1997)
cardiac asthma An asthmatic attack, the bronchoconstriction being secondary to the pulmonary congestion and oedema of left ventricular failure.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á